FDA
-
-
-
-
-
-
-
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
-
-
-
-
-
-
-
BeOne Medicines reports positive results from cancer drug trial
-
-
-
-
-
-
-
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
-
-
-
-
-
-
-
BeOne Medicines reports positive results for lymphoma drug sonrotoclax
-
-
-
-
-
-
-
BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates
-
-
-
-
-
-
-
Oncolytics Biotech regains compliance with NASDAQ minimum bid price rule
-
-
-
-
-
-
-
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®
-
328,603 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

